Citius Oncology, Inc.

CTOR ·Healthcare, Drug Manufacturers - General, United States

← 5Y 10Y MAX →

Returns on Capital

ROE ROI ROA

Fiscal Year	ROE	ROI	ROA
FY2024	-45.8%	-45.8%	-25.1%
FY2025	-55.2%	-55.2%	-24.5%